Find Research Outputs

Search concepts
Selected Filters
2017
2 Citations

Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)

Mentz, R. J., Bethel, M. A., Gustavson, S., Thompson, V. P., Pagidipati, N. J., Buse, J. B., Chan, J. C., Iqbal, N., Maggioni, A. P., Marso, S. P., Ohman, P., Poulter, N., Ramachandran, A., Zinman, B., Hernandez, A. F. & Holman, R. R. May 1 2017 In : American Heart Journal. 187, p. 1-9 9 p.

Research output: Research - peer-reviewArticle

exenatide
Glucagon-Like Peptide-1 Receptor
Placebos
Dipeptidyl-Peptidase IV Inhibitors
Cerebrovascular Disorders

Differential Use of Screening Mammography in Older Women Initiating Metformin versus Sulfonylurea

Hong, J. L., Henderson, L. M., Jonsson Funk, M., Lund, J. L., Buse, J. B., Pate, V. & Stürmer, T. Jun 1 2017 In : Pharmacoepidemiology and Drug Safety. 26, 6, p. 666-675 10 p.

Research output: Research - peer-reviewArticle

Metformin
Mammography
Breast Neoplasms
Incidence
Neoplasms
13 Citations

Hypoxia and H2O2 Dual-Sensitive Vesicles for Enhanced Glucose-Responsive Insulin Delivery

Yu, J., Qian, C., Zhang, Y., Cui, Z., Zhu, Y., Shen, Q., Ligler, F. S., Buse, J. B. & Gu, Z. Feb 8 2017 In : Nano Letters. 17, 2, p. 733-739 7 p.

Research output: Research - peer-reviewArticle

insulin
hypoxia
glucose
delivery
Insulin
8 Citations

Pancreatic safety of sitagliptin in the TECOS study

Buse, J. B., Bethel, M. A., Green, J. B., Stevens, S. R., Lokhnygina, Y., Aschner, P., Grado, C. R., Tankova, T., Wainstein, J., Josse, R., Lachin, J. M., Engel, S. S., Patel, K., Peterson, E. D., Holman, R. R. & for the TECOS Study Group Feb 1 2017 In : Diabetes Care. 40, 2, p. 164-170 7 p.

Research output: Research - peer-reviewArticle

Pancreatitis
Safety
Sitagliptin Phosphate
Pancreatic Neoplasms
Dipeptidyl-Peptidase IV Inhibitors
3 Citations

Red Blood Cells for Glucose-Responsive Insulin Delivery

Wang, C., Ye, Y., Sun, W., Yu, J., Wang, J., Lawrence, D. S., Buse, J. B. & Gu, Z. 2017 (Accepted/In press) In : Advanced Materials.

Research output: Research - peer-reviewArticle

Blood
Cells
Insulin
Glucose
Cell membranes
6 Citations

Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial

Josse, R. G., Majumdar, S. R., Zheng, Y., Adler, A., Bethel, M. A., Buse, J. B., Green, J. B., Kaufman, K. D., Rodbard, H. W., Tankova, T., Westerhout, C. M., Peterson, E. D., Holman, R. R., Armstrong, P. W. & on behalf of the TECOS Study Group Jan 1 2017 In : Diabetes, Obesity and Metabolism. 19, 1, p. 78-86 9 p.

Research output: Research - peer-reviewArticle

Type 2 Diabetes Mellitus
Sitagliptin Phosphate
Therapeutics
Confidence Intervals
Osteoporotic Fractures

Update and next steps for real-world translation of interventions for type 2 diabetes prevention: Reflections from a diabetes care editors' expert forum. Diabetes care 2016;39:1186-1201

Cefalu, W. T., Buse, J. B., Tuomilehto, J., Fleming, G. A., Ferrannini, E., Gerstein, H. C., Bennett, P. H., Ramachandran, A., Raz, I., Rosenstock, J. & Kahn, S. E. Feb 1 2017 In : Diabetes Care. 40, 2, p. e23-e24

Research output: Research - peer-reviewComment/debate

2016
12 Citations

Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes

Rodbard, H. W., Buse, J. B., Woo, V., Vilsbøll, T., Langbakke, I. H., Kvist, K. & Gough, S. C. L. Jan 1 2016 In : Diabetes, Obesity and Metabolism. 18, 1, p. 40-48 9 p.

Research output: Research - peer-reviewArticle

Glycosylated Hemoglobin A
Type 2 Diabetes Mellitus
Insulin
insulin degludec
Liraglutide
17 Citations

Chronic exposure to arsenic and markers of cardiometabolic risk: A cross-sectional study in Chihuahua, Mexico

Mendez, M. A., González-Horta, C., Sánchez-Ramírez, B., Ballinas-Casarrubias, L., Cerón, R. H., Morales, D. V., Baeza Terrazas, F. A., Ishida, M. C., Gutiérrez-Torres, D. S., Saunders, R. J., Drobná, Z., Fry, R. C., Buse, J. B., Loomis, D., García-Vargas, G. G., Del Razo, L. M. & Stýblo, M. Jan 1 2016 In : Environmental Health Perspectives. 124, 1, p. 104-111 8 p.

Research output: Research - peer-reviewArticle

Arsenic
Mexico
Cross-Sectional Studies
Water
Drinking Water
12 Citations

Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) – DEVOTE 1

Marso, S. P., McGuire, D. K., Zinman, B., Poulter, N. R., Emerson, S. S., Pieber, T. R., Pratley, R. E., Haahr, P. M., Lange, M., Frandsen, K. B., Rabøl, R. & Buse, J. B. Sep 1 2016 In : American Heart Journal. 179, p. 175-183 9 p.

Research output: Research - peer-reviewArticle

Type 2 Diabetes Mellitus
Safety
insulin degludec
Insulin Glargine
Random Allocation
1 Citations

Effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on colorectal cancer incidence and its precursors

Htoo, P. T., Buse, J. B., Gokhale, M., Marquis, M. A., Pate, V. & Stürmer, T. Aug 1 2016 In : European Journal of Clinical Pharmacology. 72, 8, p. 1013-1023 11 p.

Research output: Research - peer-reviewArticle

Dipeptidyl-Peptidase IV Inhibitors
Colorectal Neoplasms
Incidence
Glucagon-Like Peptide-1 Receptor
Confidence Intervals
40 Citations

Effect of insulin glargine up-titration vs insulin degludec/liraglutide on glycated hemoglobin levels in patients with uncontrolled type 2 diabetes: The DUAL v randomized clinical trial

Lingvay, I., Manghi, F. P., García-Hernández, P., Norwood, P., Lehmann, L., Tarp-Johansen, M. J. & Buse, J. B. Mar 1 2016 In : JAMA - Journal of the American Medical Association. 315, 9, p. 898-907 10 p.

Research output: Research - peer-reviewArticle

Glycosylated Hemoglobin A
Type 2 Diabetes Mellitus
Randomized Controlled Trials
Insulin
insulin degludec
21 Citations

Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors: A randomized clinical trial

Nissen, S. E., Wolski, K. E., Prcela, L., Wadden, T., Buse, J. B., Bakris, G., Perez, A. & Smith, S. R. Mar 8 2016 In : JAMA - Journal of the American Medical Association. 315, 10, p. 990-1004 15 p.

Research output: Research - peer-reviewArticle

Bupropion
Naltrexone
Randomized Controlled Trials
Placebos
Therapeutics
9 Citations

Efficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes: The adjunct two randomized trial

Ahren, B., Hirsch, I. B., Pieber, T. R., Mathieu, C., Gomez-Peralta, F., Hansen, T. K., Philotheou, A., Birch, S., Christiansen, E., Jensen, T. J. & Buse, J. B. Oct 1 2016 In : Diabetes Care. 39, 10, p. 1693-1701 9 p.

Research output: Research - peer-reviewArticle

Type 1 Diabetes Mellitus
Insulin
Safety
Therapeutics
Liraglutide
4 Citations

Genetic predictors of cardiovascular mortality during intensive glycemic control in type 2 diabetes: Findings from the ACCORD clinical trial

Shah, H. S., Gao, H., Morieri, M. L., Skupien, J., Marvel, S., Paré, G., Mannino, G. C., Buranasupkajorn, P., Mendonca, C., Hastings, T., Marcovina, S. M., Sigal, R. J., Gerstein, H. C., Wagner, M. J., Motsinger-Reif, A. A., Buse, J. B., Kraft, P., Mychaleckyj, J. C. & Doria, A. Nov 1 2016 In : Diabetes Care. 39, 11, p. 1915-1924 10 p.

Research output: Research - peer-reviewArticle

Type 2 Diabetes Mellitus
Clinical Trials
Mortality
Genome
Datasets
7 Citations

IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test

Holst, J. J., Buse, J. B., Rodbard, H. W., Linjawi, S., Woo, V. C., Boesgaard, T. W., Kvist, K. & Gough, S. C. Mar 1 2016 In : Journal of Diabetes Science and Technology. 10, 2, p. 389-397 9 p.

Research output: Research - peer-reviewArticle

Meals
Fasting
Glucose
Monitoring
Insulin

Incorporating concomitant medications into genome-wide analyses for the study of complex disease and drug response

Graham, H. T., Rotroff, D. M., Marvel, S. W., Buse, J. B., Havener, T. M., Wilson, A. G., Wagner, M. J., Motsinger-Reif, A. A. & The ACCORD/ACCORDion Investigators Aug 17 2016 In : Frontiers in Genetics. 7, AUG, 138

Research output: Research - peer-reviewArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Genome
Pharmaceutical Preparations
Genome-Wide Association Study
Linear Models

LEADER 7: Cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ

Rutten, G. E. H. M., Tack, C. J., Pieber, T. R., Comlekci, A., Ørsted, D. D., Baeres, F. M. M., Marso, S. P. & Buse, J. B. Jun 2 2016 In : Diabetology and Metabolic Syndrome. 8, 1, 37

Research output: Research - peer-reviewArticle

Cardiovascular Diseases
Blood Pressure
Liraglutide
LDL Cholesterol
Glycosylated Hemoglobin A
742 Citations

Liraglutide and cardiovascular outcomes in type 2 diabetes

Marso, S. P., Daniels, G. H., Frandsen, K. B., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., Steinberg, W. M., Stockner, M., Zinman, B., Bergenstal, R. M., Buse, J. B. & LEADER Steering Committee on behalf of the LEADER Trial Investigators Jul 28 2016 In : New England Journal of Medicine. 375, 4, p. 311-322 12 p.

Research output: Research - peer-reviewArticle

Type 2 Diabetes Mellitus
Liraglutide
Placebos
Confidence Intervals
Cause of Death
1 Citations

Maria gordon buse, MD: A family affair through six decades of diabetes discovery

Burant, C. F., Buse, C. R., Robinson, K. A. & Buse, J. B. Jun 1 2016 In : Diabetes Care. 39, 6, p. 852-856 5 p.

Research output: Research - peer-reviewArticle

1 Citations

Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery

Yu, J., Zhang, Y., Ye, Y., DiSanto, R., Sun, W., Ranson, D., Ligler, F. S., Buse, J. B. & Gu, Z. Feb 1 2016 In : Diabetes Technology and Therapeutics. 18, p. S54-S55

Research output: Research - peer-reviewComment/debate

Insulin
Glucose
Hypoxia
22 Citations

Microneedles Integrated with Pancreatic Cells and Synthetic Glucose-Signal Amplifiers for Smart Insulin Delivery

Ye, Y., Yu, J., Wang, C., Nguyen, N. Y., Walker, G. M., Buse, J. B. & Gu, Z. Apr 27 2016 In : Advanced Materials. 28, 16, p. 3115-3121 7 p.

Research output: Research - peer-reviewArticle

Insulin
Sugars
Glucose
Blood
Blood Glucose

More realistic power estimation for new user, active comparator studies: An empirical example

Gokhale, M., Buse, J. B., Pate, V., Marquis, M. A. & Stürmer, T. Apr 1 2016 In : Pharmacoepidemiology and Drug Safety. 25, 4, p. 462-466 5 p.

Research output: Research - peer-reviewArticle

Dipeptidyl-Peptidase IV Inhibitors
Prescriptions
Neoplasms
Thiazolidinediones
Prescription Drugs
27 Citations

Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes

Gerstein, H. C. , Beavers, D. P. , Bertoni, A. G. , Bigger, J. T. , Buse, J. B. , Craven, T. E. , Cushman, W. C. , Fonseca, V. , Geller, N. L. , Giddings, S. J. , Grimm, R. H. , Genuth, S. , Hramiak, I. , Ismail-Beigi, F. , Jimenez, C. R. L. , Kirby, R. , Probstfield, J. , Riddle, M. C. , Seaquist, E. R. , Friedewald, W. T. & 1 others ACCORD Study Group May 1 2016 In : Diabetes Care. 39, 5, p. 701-708 8 p.

Research output: Research - peer-reviewArticle

Myocardial Infarction
Type 2 Diabetes Mellitus
Cause of Death
Mortality
Random Allocation
1 Citations

Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11-14 year olds: The HEALTHY Study

Jago, R., Drews, K. L., Otvos, J. D., Willi, S. M. & Buse, J. B. Jul 1 2016 In : International Journal of Obesity. 40, 7, p. 1157-1163 7 p.

Research output: Research - peer-reviewArticle

Insulin Resistance
Body Mass Index
Obesity
Inflammation
Lipoproteins
16 Citations

Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials

DeFronzo, R. A., Buse, J. B., Kim, T., Burns, C., Skare, S., Baron, A. & Fineman, M. Aug 1 2016 In : Diabetologia. 59, 8, p. 1645-1654 10 p.

Research output: Research - peer-reviewArticle

Glucagon-Like Peptide 1
Metformin
Fasting
Glucose
Therapeutics
24 Citations

Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients with Type 2 Diabetes Previously Treated with Basal Insulin: IMAGINE 5

Buse, J. B., Rodbard, H. W., Serrano, C. T., Luo, J., Ivanyi, T., Bue-Valleskey, J., Hartman, M. L., Carey, M. A., Chang, A. M. & for the IMAGINE 5 Investigators Jan 1 2016 In : Diabetes Care. 39, 1, p. 92-100 9 p.

Research output: Research - peer-reviewArticle

Type 2 Diabetes Mellitus
Randomized Controlled Trials
Insulin
Insulin Glargine
Hemoglobins
30 Citations

Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial

Holman, R. R. , Bethel, M. A. , George, J. , Sourij, H. , Doran, Z. , Keenan, J. , Khurmi, N. S. , Mentz, R. J. , Oulhaj, A. , Buse, J. B. , Chan, J. C. , Iqbal, N. , Kundu, S. , Maggioni, A. P. , Marso, S. P. , Öhman, P. , Pencina, M. J. , Poulter, N. , Porter, L. E. , Ramachandran, A. & 2 others Zinman, B. & Hernandez, A. F. Apr 1 2016 In : American Heart Journal. 174, p. 103-110 8 p.

Research output: Research - peer-reviewArticle

exenatide
Type 2 Diabetes Mellitus
Placebos
Safety
Subcutaneous Injections
18 Citations

Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes

Weinstock, R. S. , DuBose, S. N. , Bergenstal, R. M. , Chaytor, N. S. , Peterson, C. , Olson, B. A. , Munshi, M. N. , Perrin, A. J. S. , Miller, K. M. , Beck, R. W. , Liljenquist, D. R. , Aleppo, G. , Buse, J. B. , Kruger, D. , Bhargava, A. , Goland, R. S. , Edelen, R. C. , Pratley, R. E. , Peters, A. L. , Rodriguez, H. & 6 others Ahmann, A. J., Lock, J. P., Garg, S. K., Rickels, M. R., Hirsch, I. B. & T1D Exchange Severe Hypoglycemia in Older Adults With Type 1 Diabetes Study Group Apr 1 2016 In : Diabetes Care. 39, 4, p. 603-610 8 p.

Research output: Research - peer-reviewArticle

Type 1 Diabetes Mellitus
Hypoglycemia
Glucose
Glycosylated Hemoglobin A
C-Peptide
5 Citations

The author replies: Liraglutide and cardiovascular outcomes in type 2 diabetes

Buse, J. B. Nov 3 2016 In : New England Journal of Medicine. 375, 18, p. 1798-1799 2 p.

Research output: Research - peer-reviewLetter

Type 2 Diabetes Mellitus
Liraglutide
72 Citations

The primary glucose-lowering effect of metformin resides in the gut, not the circulation: Results from short-term pharmacokinetic and 12-week dose-ranging studies

Buse, J. B., DeFronzo, R. A., Rosenstock, J., Kim, T., Burns, C., Skare, S., Baron, A. & Fineman, M. Feb 1 2016 In : Diabetes Care. 39, 2, p. 198-205 8 p.

Research output: Research - peer-reviewArticle

Metformin
Pharmacokinetics
Glucose
Placebos
Biological Availability
18 Citations

Update and next steps for real-world translation of interventions for type 2 diabetes prevention: Reflections from a diabetes care editors' expert forum

Cefalu, W. T., Buse, J. B., Tuomilehto, J., Alexander Fleming, G., Ferrannini, E., Gerstein, H. C., Bennett, P. H., Ramachandran, A., Raz, I., Rosenstock, J. & Kahn, S. E. Jul 1 2016 In : Diabetes Care. 39, 7, p. 1186-1201 16 p.

Research output: Research - peer-reviewReview article

Glucose Intolerance
Type 2 Diabetes Mellitus
Pharmacology
Population
Prediabetic State
2015
11 Citations

Cardiovascular safety of the glucagon-like peptide-1 receptor agonist taspoglutide in people with type 2 diabetes: An individual participant data meta-analysis of randomized controlled trials

Seshasai, S. R. K., Bennett, R. L., Petrie, J. R., Bengus, M., Ekman, S., Dixon, M., Herz, M., Buse, J. B. & Ray, K. K. May 1 2015 In : Diabetes, Obesity and Metabolism. 17, 5, p. 505-510 6 p.

Research output: Research - peer-reviewArticle

Type 2 Diabetes Mellitus
Meta-Analysis
Randomized Controlled Trials
Safety
taspoglutide

Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira)

Buse, J. B., Vilsbøll, T., Thurman, J., Blevins, T. C., Langbakke, I. H., Bøttcher, S. G. & Rodbard, H. W. Feb 1 2015 In : Diabetes Technology and Therapeutics. 17, p. S128-S129

Research output: Research - peer-reviewComment/debate

insulin degludec
Liraglutide
732 Citations

Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes

Green, J. B., Bethel, M. A., Armstrong, P. W., Buse, J. B., Engel, S. S., Garg, J., Josse, R., Kaufman, K. D., Koglin, J., Korn, S., Lachin, J. M., McGuire, D. K., Pencina, M. J., Standl, E., Stein, P. P., Suryawanshi, S., Van De Werf, F., Peterson, E. D. & Holman, R. R. Jul 16 2015 In : New England Journal of Medicine. 373, 3, p. 232-242 11 p.

Research output: Research - peer-reviewArticle

Type 2 Diabetes Mellitus
Sitagliptin Phosphate
Placebos
Hospitalization
Confidence Intervals
4 Citations

Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: Pooled findings from three randomized phase III trials

Henry, R. R., Buse, J. B., Wu, H., Durrwell, L., Mingrino, R., Jaekel, K., El Azzouzi, B., Andjelkovic, M. & Herz, M. Jun 1 2015 In : Diabetes, Obesity and Metabolism. 17, 6, p. 560-565 6 p.

Research output: Research - peer-reviewArticle

Type 2 Diabetes Mellitus
Safety
aleglitazar
Placebos
Metformin
199 Citations

Euglycemic diabetic ketoacidosis: A potential complication of treatment with sodium-glucose cotransporter 2 inhibition

Peters, A. L., Buschur, E. O., Buse, J. B., Cohan, P., Diner, J. C. & Hirsch, I. B. Sep 1 2015 In : Diabetes Care. 38, 9, p. 1687-1693 7 p.

Research output: Research - peer-reviewArticle

Sodium-Glucose Transport Proteins
Diabetic Ketoacidosis
Therapeutics
Inhibition (Psychology)
Type 1 Diabetes Mellitus

Evaluation des effets cardiovasculaires du liraglutide: conception et donnees de base de l'etude Liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER®)

Marre, M., Marso, S. P., Poulter, N. R., Nissen, S. E., Nauck, M. A., Zinman, B., Daniels, G. H., Pocock, S., Steinberg, W. M., Bergenstal, R. M., Mann, J. F. E., Steen Ravn, L., Brown Frandsen, K., Moses, A. C. & Buse, J. B. Jan 1 2015 In : Medecine des Maladies Metaboliques. 9, 3, p. 316-328 13 p.

Research output: Research - peer-reviewArticle

Liraglutide
Random Allocation
Type 2 Diabetes Mellitus
Stroke
Myocardial Infarction
12 Citations

Insulin dose and cardiovascular mortality in the ACCORD trial

Siraj, E. S., Rubin, D. J., Riddle, M. C., Miller, M. E., Hsu, F. C., Ismail-Beigi, F., Chen, S. H., Ambrosius, W. T., Thomas, A., Bestermann, W., Buse, J. B., Genuth, S., Joyce, C., Kovacs, C. S., O'connor, P. J., Sigal, R. J. & Solomon, S. Nov 1 2015 In : Diabetes Care. 38, 11, p. 2000-2008 9 p.

Research output: Research - peer-reviewArticle

Insulin
Mortality
Therapeutics
Hypoglycemia
Meals
14 Citations

Is insulin the most effective injectable antihyperglycaemic therapy?

Buse, J. B., Peters, A., Russell-Jones, D., Furber, S., Donsmark, M., Han, J., Macconell, L., Maggs, D. & Diamant, M. Feb 1 2015 In : Diabetes, Obesity and Metabolism. 17, 2, p. 145-151 7 p.

Research output: Research - peer-reviewArticle

Hypoglycemic Agents
Insulin
Injections
Therapeutics
Glucagon-Like Peptide-1 Receptor
5 Citations

LEADER 2: Baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: Preliminary observations

Daniels, G. H., Hegedüs, L., Marso, S. P., Nauck, M. A., Zinman, B., Bergenstal, R. M., Mann, J. F. E., Derving Karsbøl, J., Moses, A. C., Buse, J. B., Tuttle, R. M. & on behalf of the LEADER trial investigators Jan 1 2015 In : Diabetes, Obesity and Metabolism. 17, 5, p. 477-486 10 p.

Research output: Research - peer-reviewArticle

Calcitonin
Type 2 Diabetes Mellitus
Liraglutide
Serum
Glomerular Filtration Rate
258 Citations

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R. & Matthews, D. R. Feb 6 2015 In : Diabetologia. 58, 3, p. 429-442 14 p.

Research output: Research - peer-reviewEditorial

Medical Societies
Disease Management
Hypoglycemic Agents
Hyperglycemia
Type 2 Diabetes Mellitus
1082 Citations

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a position statement of the american diabetes association and the european association for the study of diabetes

Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R. & Matthews, D. R. Jan 1 2015 In : Diabetes Care. 38, 1, p. 140-149 10 p.

Research output: Research - peer-reviewArticle

5 Citations

Medications for type 2 diabetes: how will we be treating patients in 50 years?

Kahn, S. E. & Buse, J. B. Aug 23 2015 In : Diabetologia. 58, 8, p. 1735-1739 5 p.

Research output: Research - peer-reviewEditorial

Type 2 Diabetes Mellitus
Therapeutics
Anniversaries and Special Events
Hyperglycemia
Public Health
15 Citations

Metabolomic characteristics of arsenic-associated diabetes in a prospective cohort in Chihuahua, Mexico

Martin, E. , González-Horta, C. , Rager, J. , Bailey, K. A. , Sánchez-Ramírez, B. , Ballinas-Casarrubias, L. , Ishida, M. C. , Gutiérrez-Torres, D. S. , Cerón, R. H. , Morales, D. V. , Terrazas, F. A. B. , Jesse Saunders, R. , Drobná, Z. , Mendez, M. A. , Buse, J. B. , Loomisk, D. , Jiakj, W. , García-Vargaskk, G. G. , Del Razo, L. M. , Stýblo, M. & 1 others Fry, R. Jan 1 2015 In : Toxicological Sciences. 144, 2, p. 338-346 9 p.

Research output: Research - peer-reviewArticle

Arsenic
Medical problems
Metabolomics
Mexico
Metabolites
99 Citations

Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery

Yu, J., Zhang, Y., Ye, Y., DiSanto, R., Sun, W., Ranson, D., Ligler, F. S., Buse, J. B., Gu, Z. & Ho, D. Jul 7 2015 In : Proceedings of the National Academy of Sciences of the United States of America. 112, 27, p. 8260-8265 6 p.

Research output: Research - peer-reviewArticle

Insulin
Glucose
Hypoxia
Hyaluronic Acid
Equipment and Supplies
41 Citations

One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: Results of a 26-week extension to a 26-week main trial

Gough, S. C. L., Bode, B. W., Woo, V. C., Rodbard, H. W., Linjawi, S., Zacho, M., Reiter, P. D. & Buse, J. B. Oct 1 2015 In : Diabetes, Obesity and Metabolism. 17, 10, p. 965-973 9 p.

Research output: Research - peer-reviewArticle

Type 2 Diabetes Mellitus
Safety
insulin degludec
Liraglutide
Therapeutics
20 Citations

Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

Bethel, M. A., Green, J. B., Milton, J., Tajar, A., Engel, S. S., Califf, R. M., Holman, R. R., Armstrong, P. W., Buse, J. B., Josse, R. G., Kaufman, K., Koglin, J., Korn, S., Lachin, J. M., McGuire, D. K., Standl, E., Stein, P., Suryawanshi, S., Van de Werf, F. & TECOS Executive Committee Apr 1 2015 In : Diabetes, Obesity and Metabolism. 17, 4, p. 395-402 8 p.

Research output: Research - peer-reviewArticle

North America
Sex Characteristics
Therapeutics
Sitagliptin Phosphate
Eastern Europe
57 Citations

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in type 1 diabetes

Sands, A. T., Zambrowicz, B. P., Rosenstock, J., Lapuerta, P., Bode, B. W., Garg, S. K., Buse, J. B., Banks, P., Heptulla, R., Rendell, M., Cefalu, W. T. & Strumph, P. Jul 1 2015 In : Diabetes Care. 38, 7, p. 1181-1188 8 p.

Research output: Research - peer-reviewArticle

Type 1 Diabetes Mellitus
Insulin
Therapeutics
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
Placebos

Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes

Garg, S. K., Buse, J. B., Skyler, J. S., Vaughn, D. E. & Muchmore, D. B. Feb 1 2015 In : Diabetes Technology and Therapeutics. 17, p. S45-S46

Research output: Research - peer-reviewComment/debate

Insulin Lispro
Hyaluronoglucosaminidase
Subcutaneous Injections
Type 1 Diabetes Mellitus
Insulin